Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Kadmon Holdings Inc    KDMN

KADMON HOLDINGS INC

(KDMN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/18/2019 03/19/2019 03/20/2019 03/21/2019 03/22/2019 Date
2.91(c) 2.91(c) 2.86(c) 2.96(c) 2.77(c) Last
735 562 830 321 514 559 1 597 334 2 535 195 Volume
+5.05% 0.00% -1.72% +3.50% -6.42% Change
More quotes
Financials (USD)
Sales 2019 3,87 M
EBIT 2019 -93,0 M
Net income 2019 -65,6 M
Debt 2019 -
Yield 2019 -
Sales 2020 27,7 M
EBIT 2020 -83,7 M
Net income 2020 -97,1 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 -
P/E ratio 2020
Capi. / Sales2019 90,8x
Capi. / Sales2020 12,7x
Capitalization 352 M
More Financials
Company
Kadmon Holdings, Inc. is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within... 
Sector
Pharmaceuticals
Calendar
08/01Earnings Release
More about the company
Surperformance© ratings of Kadmon Holdings Inc
Trading Rating : - Investor Rating :
More Ratings
Latest news on KADMON HOLDINGS INC
03/22KADMON HOLDINGS, INC. : Change in Directors or Principal Officers, Regulation FD..
AQ
03/14KADMON : to Present at the Oppenheimer 29th Annual Healthcare Conference
AQ
03/08KADMON : Provides Business Update and Reports Fourth Quarter and Full Year 2018 ..
AQ
03/07KADMON : Management's Discussion and Analysis of Financial Condition and Results..
AQ
03/07KADMON HOLDINGS, INC. : Results of Operations and Financial Condition, Financial..
AQ
02/12KADMON : Announces Appointment of Steven Meehan as CFO
AQ
02/11KADMON HOLDINGS, INC. : Change in Directors or Principal Officers, Regulation FD..
AQ
02/11KADMON : Announces Appointment of Steven Meehan as CFO
AQ
02/08KADMON : Announces Appointment of David E. Cohen, M.D., MPH, to Board of Directo..
AQ
02/07KADMON HOLDINGS, INC. : Regulation FD Disclosure, Financial Statements and Exhib..
AQ
More news
Sector news : Biopharmaceuticals
08:57aBAYER : CEO says his team retains backing of supervisory board
RE
03/22FDA Rejects Oral Treatment for Type 1 Diabetes - Update
DJ
03/22ALLERGAN : promises independent board chair in next leadership change
RE
03/22FDA Rejects Oral Treatment for Type 1 Diabetes
DJ
03/22UPS to Test In-Home Vaccine Service in U.S. -Reuters
DJ
More sector news : Biopharmaceuticals
Chart KADMON HOLDINGS INC
Duration : Period :
Kadmon Holdings Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KADMON HOLDINGS INC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 10,7 $
Spread / Average Target 287%
EPS Revisions
Managers
NameTitle
Harlan W. Waksal President, Chief Executive Officer & Director
Anastasios G. Konidaris Chairman
John L. Ryan Chief Medical Officer & Executive Vice President
Eugene Andrew Bauer Independent Director
Dennie Dixon Boardman Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
KADMON HOLDINGS INC33.17%352
CSL LIMITED6.50%63 534
BIOGEN-27.98%42 629
ALEXION PHARMACEUTICALS33.74%29 098
SAMSUNG BIOLOGICS CO LTD--.--%19 732
GRIFOLS2.53%16 228